Amends GS 90-18.1 (authorizing physician assistants to prescribe medication) and GS 90-18.2 (authorizing nurse practitioners to prescribe medication) to change the circumstances under which physician assistants or nurse practitioners must consult with the supervising physician before prescribing a targeted controlled substance to include when the patient is being treated by a facility that primarily engages in the treatment of pain by prescribing narcotic medications (previously also include a facility that advertises in any medium for any type of pain management services). Effective October 1, 2021.